CU22041A1 - PROCEDURE FOR OBTAINING A LEUKOCYTARIAN TRANSFER FACTOR. - Google Patents

PROCEDURE FOR OBTAINING A LEUKOCYTARIAN TRANSFER FACTOR.

Info

Publication number
CU22041A1
CU22041A1 CU1987041A CU1987041A CU22041A1 CU 22041 A1 CU22041 A1 CU 22041A1 CU 1987041 A CU1987041 A CU 1987041A CU 1987041 A CU1987041 A CU 1987041A CU 22041 A1 CU22041 A1 CU 22041A1
Authority
CU
Cuba
Prior art keywords
transfer factor
obtaining
leukocytarian
procedure
leukocytes
Prior art date
Application number
CU1987041A
Other languages
Spanish (es)
Inventor
Ortega Celia Berta Fernandez
Saura Pedro Lopez
Vidal Manuel Limonta
Niebla Elisabeth Guillama
Original Assignee
Centzro De Investigaciones Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centzro De Investigaciones Bio filed Critical Centzro De Investigaciones Bio
Priority to CU1987041A priority Critical patent/CU22041A1/en
Publication of CU22041A1 publication Critical patent/CU22041A1/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

CONSISTE EN LA PREPARACION DE FACTOR DE TRANSFERENCIA A PARTIR DE LOS LEUCOCITOS PURIFICADOS DE SANGRE HUMANA. ESTOS LEUCOCITOS SON TRATADOS CON UN INDUCTOR DE INTERFERON ALFA Y DESPUES DE VARIAS HORAS DE INCUBACION SON SEPARADOS DEL MEDIO DE CULTIVO COMENZANDOSE EL PROCESO DE OBTENCION DEL FACTOR DE TRANSFERENCIA LEUCOCITARIO MEDIANTE RUPTURA CELULAR Y DIALISIS A VACIO. ESTE PRODUCTO PUEDE SER UTILIZADO EN EL TRATAMIENTO DE DIFERENTES ENFERMEDADES DE ORIGEN VIRAL, INMUNODEFICIENCIAS, ETC.\!IT CONSISTS IN THE PREPARATION OF THE TRANSFER FACTOR FROM THE PURIFIED LEUKOCYTES OF HUMAN BLOOD. THESE LEUKOCYTES ARE TREATED WITH AN ALPHA-INTERFERING INDUCTOR AND AFTER SEVERAL HOURS OF INCUBATION THEY ARE SEPARATED FROM THE CULTURE MEANS, THE PROCESS OF OBTAINING THE LEUKOCYTARY TRANSFER FACTOR BEGINNING BY CELL DIALYSIS AND A DIALYSIS. THIS PRODUCT CAN BE USED IN THE TREATMENT OF DIFFERENT DISEASES OF VIRAL ORIGIN, IMMUNODEFICIENCIES, ETC. \!

CU1987041A 1987-03-27 1987-03-27 PROCEDURE FOR OBTAINING A LEUKOCYTARIAN TRANSFER FACTOR. CU22041A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU1987041A CU22041A1 (en) 1987-03-27 1987-03-27 PROCEDURE FOR OBTAINING A LEUKOCYTARIAN TRANSFER FACTOR.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1987041A CU22041A1 (en) 1987-03-27 1987-03-27 PROCEDURE FOR OBTAINING A LEUKOCYTARIAN TRANSFER FACTOR.

Publications (1)

Publication Number Publication Date
CU22041A1 true CU22041A1 (en) 1993-04-30

Family

ID=5459251

Family Applications (1)

Application Number Title Priority Date Filing Date
CU1987041A CU22041A1 (en) 1987-03-27 1987-03-27 PROCEDURE FOR OBTAINING A LEUKOCYTARIAN TRANSFER FACTOR.

Country Status (1)

Country Link
CU (1) CU22041A1 (en)

Similar Documents

Publication Publication Date Title
ATE125820T1 (en) METHODS AND COMPOSITIONS FOR HEALING ULCERS.
DZ350A1 (en) Interferons of hybrid human leukocytes and process for their microbiological preparation.
ATE79720T1 (en) METHODS OF PRESERVING TRANSPLANTABLE EPITHELIAL TISSUES CULTURED IN VITRO.
ES2113858T3 (en) INTRODUCTION OF BACTERIA IN EGGS.
ATE2442T1 (en) PROCESS FOR THE PREPARATION OF INTERFERON AND CULTURE MEDIUM COMPOSITION USED THEREIN.
DE3781652D1 (en) PREPARATION SUITABLE FOR TREATMENT OF COLONAL DISEASES.
ES2006476A6 (en) A PROCEDURE FOR OBTAINING HUMAN INTERLEUKIN-2
BG47034A3 (en) METHOD FOR THE PREPARATION OF 7-//META-SUBSTITUTED/-PENICILLINS/- -1-CARBA-1-DETHIACEPHALOSPORINS
HUT58037A (en) Process for producing n-2,3-butadienyl tri- and tetraaminoalkane derivatives
DE3650505D1 (en) AICA riboside for the prophylactic treatment of diseases with reduced blood flow.
DE69130679D1 (en) THE PRODUCTION OF COMPOSITIONS FOR THE TREATMENT OF DISEASES OF CELL PROLIFERATION
ATE513900T1 (en) PREPARATION AND USE OF HUMAN CD124 AND CD116 POSITIVE TUMOR CELL LINES FOR PRODUCING ALLOGENE OR SEMI-ALLOGENE IMMUNTHERAPEUTICS
FI102191B1 (en) Process for producing 3-dehydroxycstatin C and a DNA sequence for use in the process
EP0094317A3 (en) Production of interleukin and its analogous immune regulating factors
SG72665A1 (en) Method and composition for determining the immunological activity of bioactive substances
Tamura et al. Induction of human γ interferon by Sarcophaga peregrina humoral lectin
ATE183204T1 (en) AMINO SUGAR, GLYCOPROTEINS, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THEIR USE
ATE154611T1 (en) NEW MEGAKARYOCYTIC COLONY-STIMULATING FACTOR AND METHOD FOR PRODUCTION
EP0145775B1 (en) A METHOD OF TREATING INTERFERON SENSITIVE DISEASES, AND A METHOD AND A DEVICE FOR PREPARING A $g(g)-INTERFERON CONTAINING PREPARATION
JPS58107197A (en) Preparation of tumor necrosis factor
DK0538330T3 (en) Beta-Alethin use for cell culture and therapy
DK183788A (en) PROCEDURE FOR INCREASING THE LIVELY OF FREEZE DRIED Lactic Acid Producing Bacteria Culture Concentrates
DE3884324D1 (en) Process for the production of human pro-apolipoprotein A-I-like proteins.
DE69116240D1 (en) Process for the production of cell protein with anti-HIV activity
DE3850933D1 (en) Anticoagulant protein PP4-X, its production and use.